References
- Bateman J. C., Moulton B., Larsen N. J. Control of neoplastic effusion by phosphoramide chemotherapy. Arch, intern. Med. 1955; 95: 713
- Cassady J. R. The inhibition of pterygium recurrence by Thiotepa. Amer. J. Ophthal. 1966; 61: 886
- Cheng S. F., Veenema R. J. Topical application of Thio-Tepa to penile and urethral tumors. J. Urol. 1965; 94: 259
- Edgren B., Forsgren L., Boström H. Grav benmärgsskada efter blåsinstallationer med tiotepa (in Swedish). Nord. Med. 1966; 75: 481
- Esqivel E. L., Jr, Mackenzie A. R., Whitmore W. F., Jr. Treatment of bladder tumors by instillation of thio-TEPA, actinomycin D or 5-fluorouracil. Invest. Urol. 1965; 2: 381
- Groesbeck H. P., Cudmore J. T. P. Intracavitary Thio-TEPA for malignant effusions. Amer. Surg. 1962; 28: 90
- Grupper C., Sirkis L. Le thiotépa en applications locales avec occlusion dans le mycosis fongoide. Bull. Soc. franc. Derm. Syph. 1965; 72: 338
- Jones H. C. The topical use of cytotoxic drugs for bladder cancer. Proc. roy. Soc. Med. 1963; 56: 751
- Michel P. J., Cretin J., Lépine Y. Prémycosis rebelle au traitement classique. Heureux résultat d'un essai de traitement local antimitotique (thiotépa) sous pansement occlusif. Bull. Soc. franc. Derm. Syph. 1965; 72: 27
- Oravisto K. J. Topical use of Thio-Tepa for tumours of the bladder. Urol. int. 1965; 20: 23
- Voutilainen A., Salmi R. Skin metastases of mammary cancer treated by Thio-TEPA solution compresses. Ann. Chir. Gynaec. Fenn. 1965; 54: 401